Becker’s Nevus Market Size, Share Report, Analysis, Trends, Growth, 2030

Becker’s Nevus Market

Becker’s Nevus Market By Type (Shoulder, Trunk, and Others), By Disease Occurrence (Birth and After Birth), By Treatment (Medication, Laser Treatment, and Others), By End User (Hospitals, Specialty Clinics, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 – 2030

Category: Pharmaceutical Report Format : PDF Pages: 224 Report Code: ZMR-7372 Published Date: Jul-2023 Status : Published
Market Size in 2022 Market Forecast in 2030 CAGR (in %) Base Year
USD 845.76 Million USD 1364.78 Million 6.17% 2022

Becker’s Nevus Industry Prospective:

The global Becker’s nevus market size was worth around USD 845.76 million in 2022 and is predicted to grow to around USD 1364.78 million by 2030 with a compound annual growth rate (CAGR) of roughly 6.17% between 2023 and 2030.

Global Becker’s Nevus Market SizeRequest Free Sample

The report analyzes the global Becker’s nevus market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Becker’s nevus market.

Becker’s Nevus Market: Overview

Becker's nevus, also known as Becker's melanosis, is a relatively common skin disorder characterized by the presence of a large, irregularly shaped patch of hyperpigmentation. It is typically seen on the shoulder, upper arm, or upper trunk, although it can occur in other areas of the body as well. It usually appears during adolescence or early adulthood, and its exact cause is not fully understood. It is believed to be a benign (non-cancerous) condition that arises from an overgrowth of melanocytes (pigment-producing cells) in the affected area of the skin.

The patch of hyperpigmentation associated with Becker's nevus is typically brown or tan, and it may have a slightly raised or rough texture. In addition to the increased pigmentation, the affected area may also have increased hair growth (hypertrichosis) and an increased number of sweat glands. Becker's nevus is more commonly seen in males than females, and it can vary in size and appearance. While it is generally a cosmetic concern and does not cause any significant medical problems, some individuals with Becker's nevus may experience psychological or emotional distress due to its appearance, particularly if it is large or located in a highly visible area. The market will rise as a result of more research being done on rare diseases and their many consequences, as well as an increase in the prevalence of skin problem complications.

Key Insights

  • As per the analysis shared by our research analyst, the global Becker’s nevus market is estimated to grow annually at a CAGR of around 6.17% over the forecast period (2023-2030).
  • In terms of revenue, the global Becker’s nevus market size was valued at around USD 845.76 million in 2022 and is projected to reach USD 1364.78 million, by 2030.
  • The growing prevalence of skin disorders across the globe is expected to drive Becker’s nevus market growth over the forecast period.
  • Based on the treatment, the laser treatment is expected to grow at the highest CAGR during the forecast period.
  • Based on the end user, the hospital segment is expected to dominate the market over the forecast period.
  • Based on the distribution channel, the online segment is expected to grow at the highest CAGR during the forecast period.
  • Based on region, North America is expected to dominate the market during the forecast period.

Global Becker's Nevus Market SizeRequest Free Sample

Becker’s Nevus Market: Growth Drivers

Collaboration between dermatology and aesthetic professionals drives the market growth

Becker's nevus treatments often involve a multidisciplinary approach that combines dermatological expertise and aesthetic services. Collaboration between dermatologists, plastic surgeons, laser specialists, and other healthcare professionals can lead to comprehensive treatment plans and better outcomes for individuals with Becker's nevus. This collaboration can create opportunities for knowledge sharing, joint research endeavors, and holistic patient care. Therefore, the collaboration between dermatology and aesthetic professionals is expected to drive the global Becker’s nevus market growth over the forecast period.

Becker’s Nevus Market: Restraints

Cost and accessibility act as major restraints for the market expansion

The cost of treatment and accessibility to specialized dermatological services can be significant restraints for Becker’s nevus industry growth. Certain treatments for Becker's nevus, such as laser therapy or cosmetic procedures, can be expensive, and not all individuals may have the financial means to pursue them. Additionally, limited access to specialized dermatology clinics or aesthetic centers in certain regions may restrict the availability of treatments.

Becker’s Nevus Market: Opportunities

Advancements in treatment technologies and growing awareness offer a significant opportunity

Becker’s nevus market may be influenced by advancements in dermatological treatment technologies. The development of innovative laser devices, light-based therapies, or topical formulations with improved efficacy and safety profiles can expand the treatment options available for Becker's nevus, attracting individuals who are looking for effective solutions. In addition, the growing awareness of Becker's nevus and available treatment options continues to grow, more individuals may seek medical intervention. This can be attributed to improved access to information through the internet, social media platforms, and patient support groups, which can educate individuals about the condition and available treatments.

Becker’s Nevus Market: Challenges

Limited research and clinical evidence pose a major challenge

Becker's nevus has not received as much research attention as other dermatological conditions. The limited availability of clinical studies and scientific data on the effectiveness and long-term outcomes of various treatment options can hinder Becker’s nevus market growth. The lack of robust evidence may deter healthcare professionals and individuals from pursuing specific treatments or investing in research and development.

Becker’s Nevus Market: Segmentation

The global Becker’s nevus industry is segmented based on type, disease occurrence, treatment, end user, distribution channel, and region.

Based on the type, the global market is bifurcated into shoulder, trunk, and others.

Based on the disease occurrence, the global Becker’s nevus industry is divided into birth and after birth.

Based on the treatment, the global market is divided into medication, laser treatment, and others. The laser treatment is expected to grow at the highest CAGR during the forecast period. Laser treatments play a significant role in managing Becker's nevus, particularly in addressing hyperpigmentation and reducing hair growth associated with the condition. Different laser modalities can be utilized, such as fractional laser, Q-switched lasers, or intense pulsed light (IPL), depending on the specific characteristics of the nevus and individual patient needs. In addition, these treatments for Becker's nevus are typically performed by dermatologists or laser specialists in specialized dermatology clinics or aesthetic centers. These professionals have expertise in laser procedures and can provide comprehensive care and treatment options tailored to individual patient needs. Thereby, driving the segment growth over the forecast period.

Based on the end user, the global Becker’s nevus industry is segmented into hospitals, specialty clinics, and others. The hospital segment is expected to dominate the market over the forecast period. Hospitals provide a platform for a multidisciplinary approach to managing Becker's nevus. This may involve collaboration between dermatologists, plastic surgeons, laser specialists, pathologists, and other healthcare professionals to develop comprehensive treatment plans and ensure holistic care for individuals with Becker's nevus. Additionally, hospitals may offer a range of treatment procedures for Becker's nevus, depending on their capabilities and expertise. This may include laser treatments (e.g., fractional laser, Q-switched lasers, or intense pulsed light), surgical excision, cryotherapy, or other relevant therapies based on individual patient needs. Thus, this is expected to drive segment growth during the forecast period.

Based on the distribution channel, the global Becker’s nevus market is bifurcated into hospital pharmacies, retail pharmacies, online pharmacies, and others. Online pharmacies are expected to grow at the highest CAGR during the forecast period. Online pharmacies provide a convenient way for individuals with Becker's nevus to access medications and topical treatments for their condition. This segment is characterized by individuals who prefer the ease of online ordering and delivery of their prescribed medications, including bleaching creams, ointments, or other dermatological products used to manage hyperpigmentation associated with Becker's nevus. Thereby, driving the segment growth.

Becker’s Nevus Market: Report Scope

Report Attributes Report Details
Report Name Becker’s Nevus Market Research Report
Market Size in 2022 USD 845.76 Million
Market Forecast in 2030 USD 1364.78 Million
Growth Rate CAGR of 6.17%
Number of Pages 225
Key Companies Covered Boehringer Ingelheim, Eisai Inc., Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Bayer Healthcare AG, Aspen Holdings, Mitsubishi Tanabe Pharma Corporation, Abbott India Limited, GlaxoSmithKline Plc., Bristol-Myers Squibb Company and Mitsubishi Tanabe Pharma Corporation among others.
Segments Covered By Type, By Disease Occurrence, By Treatment, By End User, By Distribution Channel, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2022
Historical Year 2017 to 2021
Forecast Year 2023 - 2030
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Becker’s Nevus Market: Regional Analysis

North America is expected to dominate the market during the forecast period

North America is expected to dominate the global Becker’s nevus market over the forecast period. The region, comprising countries like the United States and Canada, has a well-established healthcare infrastructure with advanced dermatology clinics, hospitals, and specialized treatment centers. This infrastructure supports the diagnosis and management of Becker's nevus, providing access to skilled dermatologists and advanced treatment options. Moreover, the region is known for its advancements in medical technology and dermatological procedures.

This can contribute to a wider range of treatment options available for Becker's nevus management, including advanced laser technologies, surgical techniques, and innovative approaches in cosmetic dermatology. Furthermore, the growing prevalence of skin disease in the region is expected to be a major factor that propels the growth of the market. For instance, according to the American Academy of Dermatology Association, one in four Americans, or 84.5 million people, were affected by skin disease. The medical, preventive, and medication expenditures associated with skin disease cost the US healthcare system $75 billion. Thus, the aforementioned facts support the expansion of the market in the region.

The Asia Pacific is expected to grow at the highest CAGR during the forecast period. The Asia Pacific region has a growing number of dermatology and aesthetic clinics that offer a range of treatments for skin conditions. These clinics may provide specialized services for Becker's nevus management, including laser treatments, topical creams, and surgical interventions. In addition, some countries in the Asia Pacific region, such as Thailand, Singapore, and South Korea, are popular destinations for medical tourism. This can attract individuals from other countries seeking specialized treatments for Becker's nevus, contributing to the market segment in these areas. Thereby, driving the segment growth.

Becker’s Nevus Market: Competitive Analysis

The global Becker’s nevus market is dominated by players like:

  • Boehringer Ingelheim
  • Eisai Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Bayer Healthcare AG
  • Aspen Holdings
  • Mitsubishi Tanabe Pharma Corporation
  • Abbott India Limited
  • GlaxoSmithKline Plc.
  • Bristol-Myers Squibb Company 
  • Mitsubishi Tanabe Pharma Corporation 

The global Becker’s nevus market is segmented as follows:

By Type

  • Shoulder
  • Trunk
  • Others

By Disease Occurrence

  • Birth
  • After Birth

By Treatment

  • Medication
  • Laser Treatment
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
 

Table Of Content

Methodology

FrequentlyAsked Questions

Becker's nevus, also known as Becker's melanosis, is a relatively common skin disorder characterized by the presence of a large, irregularly shaped patch of hyperpigmentation. It is typically seen on the shoulder, upper arm, or upper trunk, although it can occur in other areas of the body as well.

The market will rise as a result of more research being done on rare illnesses and their many consequences, as well as an increase in the prevalence of skin problem complications. Rising consumer disposable income in emerging nations and continuous technological advancement will help fuel Becker’s nevus market expansion.

According to the report, the global Becker’s nevus market size was worth around USD 845.76 million in 2022 and is predicted to grow to around USD 1364.78 million by 2030.

The global Becker’s nevus market is expected to grow at a CAGR of 6.17% during the forecast period.

  1. The global Becker’s nevus market growth is expected to be driven by North America. It is currently the world’s highest revenue-generating market owing to the prevalence of skin disease and the robust healthcare infrastructure.

The global Becker’s nevus market is dominated by players like Boehringer Ingelheim, Eisai Inc., Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Bayer Healthcare AG, Aspen Holdings, Mitsubishi Tanabe Pharma Corporation, Abbott India Limited, GlaxoSmithKline Plc., Bristol-Myers Squibb Company and Mitsubishi Tanabe Pharma Corporation among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed